Seoul, South Korea

Ji Hye Yoon

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Korea Institute of Science and Technology. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji Hye Yoon. Retrieved from https://idiyas.com/inventor/ji-hye-yoon-ktjf4mnb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji Hye Yoon: Innovator in Protein Kinase Inhibition

Introduction

Ji Hye Yoon is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit protein kinases. Her work is crucial in addressing diseases caused by abnormal cell growth.

Latest Patents

Ji Hye Yoon holds a patent for "Heteroarylamine derivatives as protein kinase inhibitors." This patent describes a heteroarylamine compound that exhibits protein kinase inhibition activity. It also includes a pharmaceutically acceptable salt and a pharmaceutical composition aimed at preventing and treating diseases associated with abnormal cell growth, utilizing the compound as an active ingredient. She has 1 patent to her name.

Career Highlights

Ji Hye Yoon is affiliated with the Korea Institute of Science and Technology, where she conducts her research and development. Her work has garnered attention for its potential applications in medical treatments and drug development.

Collaborations

Some of her notable coworkers include Tae Bo Sim and Ho Jong Yoon, who collaborate with her on various research projects.

Conclusion

Ji Hye Yoon is a dedicated inventor whose work in protein kinase inhibitors holds promise for advancing medical science. Her contributions are vital in the ongoing fight against diseases linked to abnormal cell growth.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…